Consolidated Statement Of Income

K Pharma,Inc. - Filing #7544858

Concept 2023-01-01 to
2023-06-30
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Consolidated statement of income
Statement of income
Net sales
1,000,000,000 JPY
Operating expenses
Selling, general and administrative expenses
258,890,000 JPY
353,772,000 JPY
219,491,000 JPY
Operating expenses
Cost of sales
90,000,000 JPY
Ordinary profit (loss)
651,026,000 JPY
-359,233,000 JPY
-220,892,000 JPY
Gross profit (loss)
910,000,000 JPY
Operating profit (loss)
651,109,000 JPY
-353,772,000 JPY
-219,491,000 JPY
Net sales
Non-operating income
7,000 JPY
52,000 JPY
1,000 JPY
Interest income
7,000 JPY
7,000 JPY
1,000 JPY
Non-operating income
Selling, general and administrative expenses
Cost of sales
Non-operating expenses
Other
90,000 JPY
4,000 JPY
Non-operating expenses
90,000 JPY
5,514,000 JPY
1,403,000 JPY
Share issuance costs
5,424,000 JPY
1,398,000 JPY
Extraordinary losses
36,497,000 JPY
31,293,000 JPY
8,226,000 JPY
Impairment losses
36,497,000 JPY
31,293,000 JPY
8,226,000 JPY
Gross profit
Profit (loss) before income taxes
614,528,000 JPY
-390,526,000 JPY
-229,119,000 JPY
Income taxes - current
99,755,000 JPY
1,900,000 JPY
579,000 JPY
Income taxes - deferred
JPY
-980,000 JPY
Extraordinary losses
Income taxes
99,755,000 JPY
1,900,000 JPY
-400,000 JPY
Profit (loss)
514,772,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-392,427,000 JPY
-228,718,000 JPY
-228,718,000 JPY
-228,718,000 JPY
-228,718,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.